The efficacy of RGD modified liposomes loaded with vinorelbine plus tetrandrine in treating resistant brain glioma

References

• Adams, J.M. and Cory, S., 2007. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene, 26 (9), 1324–1337.
   PubMed Web of Science ®Google Scholar
• Cazzaniga, M.E., et al., 2016. Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung cancer: current status and future development. Future oncology, 12 (3), 373–387.
   PubMed Web of Science ®Google Scholar
• Chen, J., et al., 2012. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature, 488 (7412), 522–526.
   PubMed Web of Science ®Google Scholar
• Cheng, D., et al., 2012. Multifunctional nanocarrier mediated co-delivery of doxorubicin and siRNA for synergistic enhancement of glioma apoptosis in rat. Biomaterials, 33 (4), 1170–1179.
   PubMed Web of Science ®Google Scholar
• Deeken, J.F. and Loscher, W., 2007. The blood-brain barrier and cancer: transporters, treatment, and Trojan horses. Clinical cancer research, 13 (6), 1663–1674.
   PubMed Web of Science ®Google Scholar
• Du, J., et al., 2009. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals. Molecular pharmaceutics, 6, 905–917.
   PubMed Web of Science ®Google Scholar
• Gao, H., et al., 2014. Glioma targeting and anti-glioma effect of interleukin 13 peptide and RGD peptide dual functionalized nanoparticles. Current pharmaceutical biotechnology, 14, 1118–1126.
   PubMed Web of Science ®Google Scholar
• Hao, L., et al., 2016. Hyperbaric oxygen preconditioning ameliorates blood-brain barrier damage induced by hypoxia through modulation of tight junction proteins in an in vitro model. Croatian medical journal, 57 (1), 51–57.
   PubMed Web of Science ®Google Scholar
• Hu, K., et al., 2009. Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations. Journal of controlled release, 134 (1), 55–61.
   PubMed Web of Science ®Google Scholar
• Jia, L., et al., 2015. Multifunctional mesoporous silica nanoparticles mediated co-delivery of paclitaxel and tetrandrine for overcoming multidrug resistance. International journal of pharmaceutics, 489 (1–2), 318–330.
   PubMed Web of Science ®Google Scholar
• Ju, R.J., et al., 2014. Liposomes, modified with PTD peptide, containing epirubicin and celecoxib, to target vasculogenic mimicry channels in invasive breast cancer. Biomaterials, 35 (26), 7610–7621.
   PubMed Web of Science ®Google Scholar
• Li, N., et al., 2013. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways. Biomaterials, 34 (13), 3366–3380.
   PubMed Web of Science ®Google Scholar
• Li, X.T., et al., 2015. PEGylated VRB plus quinacrine cationic liposomes for treating non-small cell lung cancer. Journal of drug targeting, 23 (3), 232–243.
   PubMed Web of Science ®Google Scholar
• Li, X.T., et al., 2015b. The antitumor activity of PNA modified vinblastine cationic liposomes on Lewis lung tumor cells: In vitro and in vivo evaluation. International journal of pharmaceutics, 487, 223–233.
   PubMed Web of Science ®Google Scholar
• Li, X.T., et al., 2014a. Multifunctional targeting daunorubicin plus quinacrine liposomes, modified by wheat germ agglutinin and tamoxifen, for treating brain glioma and glioma stem cells. Oncotarget, 5, 6497–6511.
   PubMed Web of Science ®Google Scholar
• Li, X.Y., et al., 2014b. Multifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain glioma. Biomaterials, 35, 5591–5604.
   PubMed Web of Science ®Google Scholar
• Li, X.T., et al., 2016. Multifunctional targeting vinorelbine plus tetrandrine liposomes for treating brain glioma along with eliminating glioma stem cells. Oncotarget, 7 (17), 24604–24622.
   PubMed Web of Science ®Google Scholar
• Li, W., et al., 2011. RGD-targeted paramagnetic liposomes for early detection of tumor: in vitro and in vivo studies. European journal of radiology, 80 (2), 598–606.
   PubMed Web of Science ®Google Scholar
• Liang, G.W., et al., 2008. Enhanced therapeutic effects on the multi-drug resistant human leukemia cells in vitro and xenograft in mice using the stealthy liposomal vincristine plus quinacrine. Fundamental & clinical pharmacology, 22, 429–437.
   PubMed Web of Science ®Google Scholar
• Liu, S., et al., 2016. The homing and inhibiting effects of hNSCs-BMP4 on human glioma stem cells. Oncotarget, 7 (14), 17920–17931.
   PubMed Web of Science ®Google Scholar
• Liu, X.Y., et al., 2010. Preparation of RGD-modified long circulating liposome loading matrine, and its in vitro anti-cancer effects. International journal of medical sciences, 7 (4), 197–208.
   PubMed Web of Science ®Google Scholar
• Liu, T., Liu, X., and Li, W., 2016b. Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy. Oncotarget, 26, 40800–40815.
   Google Scholar
• Romsicki, Y., and Sharom, F.J., 2001. Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter. Biochemistry-US, 40 (23), 6937–6947.
   PubMed Web of Science ®Google Scholar
• Sang, D.P., Li, R.J., and Lan, Q., 2014. Quercetin sensitizes human glioblastoma cells to temozolomide in vitro via inhibition of Hsp27. Acta pharmacologica sinica, 35 (6), 832–838.
   PubMed Web of Science ®Google Scholar
• Schinkel, A., et al., 1994. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell, 77, 491–502.
   PubMed Web of Science ®Google Scholar
• Schmitt, S.M., Stefan, K., and Wiese, M., 2016. Pyrrolopyrimidine derivatives as novel inhibitors of multidrug resistance-associated Protein 1 (MRP1, ABCC1). Journal of medicinal chemistry, 59 (7), 3018–3033.
   PubMed Web of Science ®Google Scholar
• Shi, J.F., et al., 2015. A combination of targeted sunitinib liposomes and targeted vinorelbine liposomes for treating invasive breast cancer. Journal of biomedical nanotechnology, 11 (9), 1568–1582.
   PubMed Web of Science ®Google Scholar
• Subr, V., et al., 2015. Polymer inhibitors of ABC transporter overcoming multidrug resistance: synthesis, characterization and in vitro evaluation. Journal of controlled release, 213, e107–e108.
   PubMed Web of Science ®Google Scholar
• Sun, M.G., et al., 2015. Targeting epirubicin plus quinacrine liposomes modified with DSPE-PEG2000-C(RGDfK) conjugate for eliminating invasive breast cancer. Journal biomedical nanotechnology, 11, 1339–1353.
   PubMed Web of Science ®Google Scholar
• Tian, W., et al., 2010. Enhanced efficacy of functionalized epirubicin liposomes in treating brain glioma-bearing rats. European journal of pharmaceutical sciences, 41 (2), 232–243.
   PubMed Web of Science ®Google Scholar
• Wang, X.X., et al., 2011. The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells. Biomaterials, 32 (24), 5673–5687.
   PubMed Web of Science ®Google Scholar
• Xu, M., et al., 2016. Distinct characterization of two vinorelbine-resistant breast cancer cell lines developed by different strategies. Oncology reports, 35, 2355–2363.
   PubMed Web of Science ®Google Scholar
• Zhang, C.X., et al., 2015. A nanostructure of functional targeting epirubicin liposomes dually modified with aminophenyl glucose and cyclic pentapeptide used for brain glioblastoma treatment. Oncotarget, 6 (32), 32681–32700.
   PubMed Web of Science ®Google Scholar
• Zhang, W., et al., 2016. Omega-3 polyunsaturated fatty acids mitigate blood-brain barrier disruption after hypoxic-ischemic brain injury. Neurobiology of disease, 91, 37–46.
   PubMed Web of Science ®Google Scholar
• Zhang, L., et al., 2011. RGD-modified PEG-PAMAM-DOX conjugates: in vitro and in vivo studies for glioma. European journal of pharmaceutics and biopharmaceutics, 79 (2), 232–240.
   PubMed Web of Science ®Google Scholar
• Zhao, Y., et al., 2016. Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity. Journal of controlled release, 222, 56–66.
   PubMed Web of Science ®Google Scholar